1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4) (1BnTIQ), An Endogenous Neurotoxin, Induces Dopaminergic Cell Death Through Apoptosis
-
Add time:09/04/2019 Source:sciencedirect.com
Endogenous MPTP-like neurotoxins such as 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4) (1BnTIQ) have been suspected in the etiology of Parkinson’s disease (PD). 1BnTIQ was found in a concentration three times higher in cerebrospinal fluid of PD brains than control subjects [J. Neurochem. 65 (6) (1995) 2633]. In the present study, we have evaluated the mechanisms of 1BnTIQ toxicity in human dopaminergic SH-SY5Y cells and tested the neuroprotective action of SKF-38393, a dopamine receptor (D1) agonist. 1BnTIQ dose dependently decreased cell viability in dopaminergic SH-SY5Y cells and the extent of cell death was more pronounced when compared to MPP+. Similar to MPP+, 1BnTIQ significantly decreased [3H]dopamine uptake. 1BnTIQ significantly increased lipid peroxidation, Bax expression, and active caspase-3 formation. Furthermore, it decreased the expression of Bcl-xL, an anti-apoptotic protein, in these cells. SKF-38393, a dopamine receptor (D1) agonist (1 and 10 μM) completely prevented the cell death and significantly increased cell viability. These results strongly suggest that 1BnTIQ induces dopaminergic cell death by apoptosis and dopamine receptor agonists may be useful neuroprotective agents against 1BnTIQ toxicity.
We also recommend Trading Suppliers and Manufacturers of 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4). Pls Click Website Link as below: cas 19716-56-4 suppliers
Prev:Original contributionNeurotoxicity of an endogenous brain amine, 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4), in organotypic slice co-culture of mesencephalon and striatum
Next:NeuropharmacologyResearch PaperSingle administration of 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4) increases the extracellular concentration of dopamine in rat striatum) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A convenient synthesis of 2-methoxy-1-naphthyl sulfoxides in high enantiomeric purity. A new asymmetric synthesis of 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4)s☆09/09/2019
- Short communicationDeprenyl decreases an endogenous parkinsonism-inducing compound, 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4) in mice: in vivo and in vitro studies09/08/2019
- Chronic administration of 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4), an endogenous amine in the brain, induces parkinsonism in a primate☆09/07/2019
- Short communicationBiochemical and pathological study of endogenous 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4)-induced parkinsonism in the mouse09/06/2019
- NeuropharmacologyResearch PaperSingle administration of 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4) increases the extracellular concentration of dopamine in rat striatum09/05/2019
- Original contributionNeurotoxicity of an endogenous brain amine, 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4), in organotypic slice co-culture of mesencephalon and striatum09/03/2019
- Short communicationNo reduction of dopamine transporter binding sites in mice following treatment with the TIQ analogue 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4)09/02/2019
- Controlling stereoselectivity by enzymatic and chemical means to access enantiomerically pure (1S,3R)-1-benzyl-2,3-dimethyl-1,2,3,4-tetrahydroisoquinoline derivatives09/01/2019
- 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4) passes through the blood–brain barrier of rat brain: An in vivo microdialysis study08/31/2019


